BioRN honorary membership for Prof. Stefan Meuer and Dr. Friedrich Richter
BioRN 2018 Members’ assembly has been the occasion to award Prof. Stefan Meuer and Dr. Friedrich Richter with BioRN honorary membership for their long-lasting and outstanding contribution to the BioRN Network.
Prof. S. Meuer and Dr. C. Tidona (Chair of BioRN Startegic Advisory Board)
Prof. Meuer has been chairing the Executive Board of BioRN Network e.V. since 2001 (still under the name of BioRegion Rhein-Neckar-Dreieck e.V.). Only one year ago he passed his role to Dr. Gitte Neubauer and remained member of the board to guarantee a fluid handover. His contribution to the development and success of this network is undisputable. Among others it is worth to mention the Leading-edge Cluster Competition won by BioRN in 2008.
Dr. Friedrich Richter has been board member of BioRN Network e.V. for seven years, before taking over the position of Managing Director of BioRN in 2017. Dr. Friedrich Richter contributed to the cluster strategy and activities especially by sharing his extraordinary experience in the pharma industry
Moreover, the Members’ Assembly elected Prof. Magnus von Knebel Doeberitz new member of the executive board. Since 2001, he is Director of the Department of Applied Tumor Biology in the Institute of Pathology at the University of Heidelberg and the Scientific Cooperation Unit “Cancer Early Detection” German Cancer Research Center. In addition, Thomas Hegendoerfer, New Ventures Lead in Germany for Johnson & Johnson Innovation has been elected new member in the strategic advisory board.
We look forward to another year of joint efforts, activities and initiatives together with our members to develop the BioRN region into a world-leading life science cluster.
BioRN is a life science research and industry cluster dedicated to the development of cell-specific, molecular and personalised innovative treatments. The BioRN Cluster stands for the development, networking, representation and promotion of the life science region into one of the leading life science clusters in Europe. The cluster-members include renowned academic research institutions such as the Universities of Heidelberg, the German Cancer Research Center (DKFZ) and the European Molecular Biology Laboratory (EMBL) and big pharmaceutical companies such as AbbVie, Boehringer Ingelheim, Johnson & Johnson, Merck, Roche, und Sanofi-Aventis, and about 80 small and medium-sized biotech enterprises. Beyond the members registered in the cluster, BioRN gives access to a wider network via partnerships and collaborations. In terms of the use of clusters for the internationalization of companies, BioRN has founded, together with Leuven (Belgium), Maastricht (Netherlands) and Copenhagen (Denmark), an alliance for the enforcement of biomedical innovation in Europe, called the Health Axis Europe.